Orgenesis Inc (ORGS) 0.6499 $ORGS Orgenesis Signs Cell

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Orgenesis Inc (ORGS) 0.6499 $ORGS

Orgenesis Signs Cell Therapy Product Development Memorandum of Understanding with CureCell of Korea
Marketwired - Wed Apr 08, 12:25PM CDT
Orgenesis Ltd., a wholly-owned subsidiary of Orgenesis Inc. (OTCQB: ORGS), a cell therapy and regenerative medicine company with a novel therapeutic technology dedicated to converting a patient's own cells into functioning insulin-producing cells as a treatment for diabetes, today announced it has entered a non-binding memorandum of understanding (MOU) with Korean company CureCell Co., Ltd.

Orgenesis to Collaborate With the Global Stem Cell & Regenerative Medicine Acceleration Center of Korea
Marketwired - Tue Apr 07, 1:27PM CDT
Orgenesis Inc. (OTCQB: ORGS) a cell therapy and regenerative medicine company with a novel therapeutic technology dedicated to converting a patient's own liver cells into functioning insulin-producing cells as a treatment for diabetes, today announced it has signed a collaboration (MOU) with the Global Stem Cell & Regenerative Medicine Acceleration Center (GSRAC) commissioned by Ministry of Health and Welfare of Korea.

Orgenesis Appoints Itamar Raz as Newest Member of Board of Advisors
Marketwired - Mon Mar 16, 7:00AM CDT
Orgenesis Inc. (OTCQB: ORGS) a development-stage company with a novel therapeutic technology dedicated to converting a patient's own liver cells into functioning insulin-producing cells as a treatment for diabetes, today announced that Professor Itamar Raz has been appointed to the Orgenesis board of advisors.

Organesis acquires Belgian cell therapy manufacturer
Seeking Alpha - at Seeking Alpha - Mon Mar 09, 9:05AM CDT


Orgenesis Acquires Cell Therapy Manufacturer MaSTherCell
Marketwired - Mon Mar 09, 5:00AM CDT
Orgenesis Inc. (OTCQB: ORGS) ("Orgenesis" or the "Company", a leader in the emerging fields of cellular therapy and re-generative medicine for the treatment of Type 1 Diabetes, today announced the Company's plan to increase its global presence and capabilities by acquiring MaSTherCell, an emerging pioneer in the industrialization of cell-based therapeutics, based in Gosselies, Belgium.

Orgenesis and Pall Corporation Receive $800,000 Grant From BIRD Foundation for Diabetes Research and Development
Marketwired - Mon Jan 26, 7:49AM CST
Orgenesis Ltd., a wholly-owned subsidiary of Orgenesis Inc. (OTCQB: ORGS), a leader in the emerging fields of cellular therapy and regenerative medicine, today announced that Orgenesis and Pall Corporation have received an $800,000 grant from the Israel-U.S. Binational Industrial Research and Development ("BIRD" Foundation to finance their current $1,600,000 co-development program.
PLL: 99.36 (-0.02)

Orgenesis Approved for EUR 2.015.000 Grant to Support Development of Its Type 1 Diabetes Program in Europe
Marketwired - Mon Nov 24, 2:21PM CST
Orgenesis SPRL, a subsidiary of Orgenesis Inc. (OTCQB: ORGS), a leader in the emerging fields of cellular therapy and regenerative medicine, today announced that it has received the formal approval from the Walloon Region, Belgium (Service Public of Wallonia, DG06) for a EUR 2,015 million support program for the research and development of a potential cure for Type 1 Diabetes.

Orgenesis Receives Patent for Potential Cure for Type 1 Diabetes
Marketwired - Wed Oct 15, 6:01AM CDT
Orgenesis Inc. (OTCQB: ORGS), a leader in the emerging fields of cellular therapy and regenerative medicine, today announced that it has received a patent for the technology supporting its unique cell-based therapy, which is being developed as a potential cure for Type 1 Diabetes. The U.S. patent No. 8,778,899, was granted for "Methods of Inducing Regulated Pancreatic Hormone Production in Non-pancreatic Islet Tissues" and recognizes the pioneering work done by Dr. Sarah Ferber and the research team at Orgenesis who have used the technology to successfully reprogram human liver cells into glucose-responsive, fully functional Insulin Producing Cells (IPCs).

Scott Carmer Named as CEO of Orgenesis North America
Marketwire - Mon Aug 04, 8:03AM CDT
Orgenesis Inc. (OTCQB: ORGS), a leader in the emerging fields of cellular therapy and re-generative medicine, today announced the appointment of industry veteran Scott Carmer as CEO of the company's North American subsidiary. Carmer has more than 25 years of diverse industry experience within both pharmaceutical and biotech companies.

Orgenesis Signs Agreement With MaSTherCell to Scale Manufacturing of Insulin-Producing Liver Cells to Combat Diabetes
Marketwire - Mon Jul 07, 7:40AM CDT
Orgenesis Inc. (OTCQB: ORGS), a leader in the emerging fields of cellular therapy and re-generative medicine today announced that its Belgian subsidiary, Orgenesis SPRL, has signed a strategic agreement with MaSTherCell SA of Gosselies, Belgium. Orgenesis believes that the agreement will enable Orgenesis to advance its manufacturing (GMP) process from lab scale to clinical scale as it prepares for Phase I and Phase II clinical trials.

Orgenesis Receives $1.5 Million Term Loan to Help Fund Breakthrough Innovation in Diabetes Research
Marketwire - Wed Jun 25, 7:31AM CDT
Orgenesis Inc. (OTCQB: ORGS), a leader in the emerging fields of cellular therapy and re-generative medicine, announced today that it raised $1.5 million via a senior secured term loan facility.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duke Energy's Cost-Protection Plan Shields Ratepayers

Updated Category News Views 19

Shielding Customers From Data Center Costs Let's get right into the thick of it: Duke Energy's latest move is a strategic one, shrouded in industry terms but with a real impact on regular folks' wallets. The company's agreement with heavyweights like Amazon, Google, and Meta aims to protect existing customers in North Carolina from getting hit with the costs of powering...

Continue Reading
Wally Disrupts Dental Industry with $25M Funding

Updated Category News Views 24

A New Breath of Fresh Air for Dental Care Dental visits—a tedious, costly affair we've all dreaded. So, when Wally rolls out an overhaul in this stale landscape, it's worth taking notice. With $25 million in their pockets from Series A funding led by Maveron, Wally's swaggering in with a plan to flip the script on dental care across the nation. Redefining the Dental...

Continue Reading
OCI N.V. Secures a Win in Court; EGM Proceeds as Planned

Updated Category News Views 25

OCI Dodges a Bullet in Amsterdam Court Stepping into the courtroom drama, OCI N.V. just took home a win as the Amsterdam Court of Appeal's Enterprise Chamber gave them a clean bill of health, kicking out the inquiry request from VEB and a bunch of other shareholders. The judges weren't convinced there was anything fishy going on, so they tossed the inquiry petition and...

Continue Reading
U. of Phoenix and LACCD Launch 3+1 Degree Pathway

Updated Category News Views 17

Opening the Floodgates for Ambitious Community College Students When it comes to climbing the educational ladder, not everyone starts at the same rung. That's a fact we've all come to terms with in one way or another. Enter the University of Phoenix and the Los Angeles Community College District with a solution to expand educational access. The 3+1 Program: A Cost-Saving...

Continue Reading
Decoding CarBravo-Certified vs Traditional Used Cars

Updated Category News Views 21

What’s Behind Door Number One: CarBravo Certification When you walk onto a car lot these days, it's a mixed bag: shiny badges boasting certifications or basic used car signage. For anyone who's spent time around cars, two types stick out—there’s your CarBravo-certified vehicles and your good ol' used cars. Now, Marissa McCoy and Jill Maniaci from Heidebreicht...

Continue Reading
Merit Expands in New York with Bold Acquisition Move

Updated Category News Views 21

Merit Financial's Growth Trajectory Takes a Leap You watch the movers and shakers in this game long enough, and you start to see patterns. Merit Financial Advisors is one of those juggernauts you'd better keep an eye on. These folks just scooped up Moldenhauer & Associates—a firm that's been a staple in Orchard Park, New York—for a cool $1.1 billion worth of client...

Continue Reading
Ornellaia's 2026 Harvest: Adapting to Nature's Whims

Updated Category News Views 15

A Year Marked by Weather's Unpredictable Dance Nobody said making wine was a walk in the park, and the folks at Ornellaia know better than most how to roll with whatever nature throws their way. The 2026 harvest story is as much about unlocking the secrets of the soil as it is about navigating the quirks of the weather. Situated in Bolgheri, Italy, this year's vintage...

Continue Reading
C3EL Expands Federal Footprint with Strategic Contracts

Updated Category News Views 9

Pushing Boundaries in Federal Contracts What a ride C3EL's had in Government Fiscal Year 2026! Let me tell you, they’ve bagged a bunch of contracts that’d make any company’s mouth water. Kicking things off, they snagged a prime cybersecurity contract from the U.S. Air Force. Considering our current cybersecurity landscape, that's like striking gold. But they...

Continue Reading
Gong, Agentforce, Avoma Crowned 2026 CI Champions

Updated Category News Views 25

Diving Deep into Conversation Intelligence There's a lot to unpack when three software titans hog the spotlight, and that's exactly what's happening in the world of conversation intelligence this year. It's like we've hit the jackpot with Gong, Agentforce Sales, and Avoma carving out their turf as the 2026 Champions, according to the venerable Info-Tech Research Group....

Continue Reading
EMCO's New Automated Facility Could Shake Industry

Updated Category News Views 22

A Novel Leap in Production Capacity EMCO Industries just put a solid foot on the accelerator with their brand-new, shiny, fully automated plant over in Claremore, Oklahoma. If you're glancing at heavy-duty trailer springs, you can't ignore the fact that this is a multimillion-dollar investment. Heck, this monstrous 30,000-square-foot facility more than doubles what EMCO...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding Shareholder Rights for Fluor Corporation Investors

Updated Category News Views 136

Important Notice for Fluor Corporation Shareholders The Gross Law Firm is reaching out to shareholders of Fluor Corporation (NYSE: FLR) with a timely update. Shareholders who purchased shares during the recently identified class period are encouraged to engage with the firm about potential legal rights and remedies. It is crucial to act quickly as the deadline for class...

Continue Reading
CARGO Therapeutics Merger Investigation: Shareholders Take Note

Updated Category News Views 181

Understanding the CARGO Therapeutics Merger In a recent development, attorney Juan Monteverde is looking into the merger involving CARGO Therapeutics, Inc. (NASDAQ: CRGX). This merger is particularly significant as it involves Concentra Biosciences, LLC, which proposes to acquire CARGO for $4.379 in cash per share. Additionally, shareholders will gain a non-transferable...

Continue Reading
Veralto Declares Consistent Quarterly Dividend for Investors

Updated Category News Views 63

Veralto's Quarterly Dividend Announcement Veralto (NYSE: VLTO), a leading name in water and product quality solutions, has announced a quarterly dividend of $0.09 per share. This decision underscores Veralto's unwavering commitment to its shareholders and its ongoing financial health. Understanding Dividend Payments Dividends often indicate a company's financial...

Continue Reading
Swvl Partners with G4S for Advanced Mobility Solutions in Saudi Arabia

Updated Category News Views 230

Swvl Partners for Fleet Efficiency Swvl Holdings Corp, a prominent provider of technology-driven mobility solutions, has recently secured a three-year contract with G4S, a leading facility management company. This collaboration is set to revolutionize fleet operations in Saudi Arabia, marking an important milestone in Swvl's efforts to expand its SaaS-based offerings....

Continue Reading
Boliden AB Reports Significant Increase in Share Capital

Updated Category News Views 108

Boliden AB Reports Substantial Increase in Share Capital Boliden AB, well-regarded in the minerals and metallurgy sector, recently reported a considerable boost to its number of shares and overall share capital. This increase follows the company's successful directed share issue of 10,714,285 shares, which also equates to a corresponding increase in voting rights. Details...

Continue Reading